Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 4.16% is 59% above its 5-year average of 2.62%, near the high end of its 5-year range (1.15%–4.16%).
As of the fiscal period ended Tuesday, June 30, 2026. 26.06% above its 12-month average of 3.30%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.16%.
DEBT TO ASSETS RATIO
4.16%
DEBT TO ASSETS RATIO AVG TTM
3.30%
DEBT TO ASSETS RATIO AVG 3Y
3.17%
DEBT TO ASSETS RATIO AVG 5Y
2.62%
DEBT TO ASSETS RATIO AVG 10Y
3.13%
DEBT TO ASSETS RATIO AVG 15Y
3.72%
DEBT TO ASSETS RATIO AVG 20Y
24.93%
CURRENT VS TTM AVG
+26.06%
CURRENT VS 3Y AVG
+31.22%
CURRENT VS 5Y AVG
+58.99%
CURRENT VS 10Y AVG
+32.73%
CURRENT VS 15Y AVG
+11.84%
CURRENT VS 20Y AVG
-83.31%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 592 covered companies
CURRENT VS SECTOR MEDIAN
+4060.49%
vs the sector median at left
Kura Oncology, Inc.
Market Cap
$932.13M
Debt to Assets Ratio
4.16%
TTM Avg
3.30%
3Y Avg
3.17%
5Y Avg
2.62%
Market Cap
$926.95M
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$917.50M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$976.15M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$882.16M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$983.51M
Debt to Assets Ratio
0.28%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$987.64M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kura Oncology, Inc. (KURA) | $932.13M | 4.16% | 3.30% | 3.17% | 2.62% |
| CeriBell, Inc. (CBLL)vs › | $928.68M | 0.13% | N/A | N/A | N/A |
| MoonLake Immunotherapeutics (MLTX)vs › | $926.95M | 0.18% | N/A | N/A | N/A |
| HealthStream, Inc. (HSTM)vs › | $917.50M | 0.03% | N/A | N/A | N/A |
| Bioventus Inc. (BVS)vs › | $890.64M | 0.39% | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $976.15M | 0.01% | N/A | N/A | N/A |
| Arbutus Biopharma Corp (ABUS)vs › | $882.16M | 0.01% | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $983.51M | 0.28% | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $987.64M | 0.02% | N/A | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $991.84M | N/A | N/A | N/A | N/A |
Debt/Assets
4.2%
Debt/Equity
0.50
Current Ratio
4.73
Interest Coverage
-200.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 4.16% |
| 2026-03-31 | 3.72% |
| 2025-12-31 | 2.77% |
| 2025-09-30 | 3.00% |
| 2025-06-30 | 2.85% |
| 2025-03-31 | 2.60% |
| 2024-12-31 | 2.18% |
| 2024-09-30 | 3.47% |
| 2024-06-30 | 3.25% |
| 2024-03-31 | 3.06% |
| 2023-12-31 | 3.83% |
| 2023-09-30 | 3.68% |
| 2023-06-30 | 2.64% |
| 2023-03-31 | 3.18% |
| 2022-12-31 | 3.07% |
| 2022-09-30 | 1.20% |
| 2022-06-30 | 1.25% |
| 2022-03-31 | 1.28% |
| 2021-12-31 | 1.29% |
| 2021-09-30 | 1.31% |
| 2021-06-30 | 1.15% |
| 2021-03-31 | 2.22% |
| 2020-12-31 | 2.31% |
| 2020-09-30 | 4.54% |
| 2020-06-30 | 4.32% |
| 2020-03-31 | 3.31% |
| 2019-12-31 | 3.20% |
| 2019-09-30 | 2.95% |
| 2019-06-30 | 2.82% |
| 2019-03-31 | 4.42% |
| 2018-12-31 | 4.11% |
| 2018-09-30 | 3.27% |
| 2018-06-30 | 5.37% |
| 2018-03-31 | 5.06% |
| 2017-12-31 | 7.41% |
| 2017-09-30 | 6.83% |
| 2017-06-30 | 13.17% |
| 2017-03-31 | 11.85% |
| 2016-12-31 | 10.49% |
| 2016-09-30 | 9.58% |
| 2016-06-30 | 8.92% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 4453.95% |
| 2014-09-30 | 1372.34% |
| 2014-06-30 | 4473.36% |
| 2014-03-31 | 3238.63% |
| 2013-12-31 | 2426.11% |
| 2013-09-30 | 1471.08% |
| 2013-06-30 | 1176.16% |
| 2013-03-31 | 4222.55% |
| 2012-12-31 | 2047.70% |
| 2012-09-30 | 1483.29% |
| 2012-06-30 | 1080.67% |
| 2012-03-31 | 697.64% |
| 2011-12-31 | 1785.71% |
| 2011-09-30 | 1139.60% |
| 2011-06-30 | 773.94% |
| 2011-03-31 | 237.54% |
| 2010-12-31 | 204.10% |
| 2010-09-30 | 582.94% |
| 2010-06-30 | 307.42% |
| 2010-03-31 | 227.38% |
| 2009-09-30 | 155.95% |
| 2009-06-30 | 117.51% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
